Am J Transplant, Volume 17, Suppl 3 Archives - Page 19 of 181 - ATC Abstracts

2017 American Transplant Congress
Biliary Complications Following Liver Transplantation – Single-Center Experience Over Three Decades and Recent Risk Factors.
A. Kaltenborn, A. Gutcke, H. Schrem, J. Gwiasda.
Core Facility Quality Management Transplantation, Hannover Medical School, Hannover, Germany
This study aims to identify independent risk factors for biliary complications after liver transplantation over 3 decades in a large single center. 1607 consecutive liver…
2017 American Transplant Congress
Complications Requiring Reoperation After Pediatric Liver Transplantation.
D. Yoeli, J. Moffett, K. Hosek, R. Ackah, R. Sigireddi, M. Kueht, N. Galvan, R. Cotton, A. Rana, C. O'Mahony, J. Goss.
Department of Surgery, Baylor College of Medicine, Houston, TX
Context: Reoperative complications after liver transplantation have been shown to decrease patient and graft survival in adults; this effect, however, has not been studied in…
2017 American Transplant Congress
Safety of Liver Donation from Living Donors with Sickle Cell Trait.
H. Elsiesy,^1,2 M. Sturdevant,¹ W. Al-Hamoudi,¹ H. Elbeshbeshy,¹ M. Al Sebayel,¹ A. Jaafari,¹ F. Abaalkhail.^1,2
¹Liver Trasplantation, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia; ²Medicine, Alfaisal University, Riyadh, Saudi Arabia; ³Gastroenterology, King Saud University, Riyadh, Saudi Arabia
Background:Living donor liver transplant (LDLT) is an important source of organs particularly with the cadaveric organ shortage. It is the main source of liver transplant…
2017 American Transplant Congress
Preoperative Pulmonary Hypertension Is Not Associated with Adverse Outcomes After Lung Transplantation.
S. Biswas Roy,¹ M. Olson,² D. Harned,¹ P. Kang,³ R. Panchanathan,³ A. Hashimi,¹ J. Huang,¹ H. Abdelrazek,¹ V. Patel,¹ A. Omar,¹ R. Bremner,¹ M. Smith,¹ R. Walia,¹ A. Kalya.⁴
¹Norton Thoracic Institute, Phoenix; ²Grand Canyon University, Phoenix; ³University of Arizona, Phoenix; ⁴St. Joseph's Hospital and Medical Center, Phoenix
Purpose: The effect of preoperative pulmonary hypertension (PH)[mdash]that is, mean pulmonary artery pressure (mPAP) of 25mmHg or higher[mdash]on lung transplantation (LTx) outcomes is debatable.Methods: We…
2017 American Transplant Congress
HLA, ANA, and ANCA Negative Vasculitis in Lung Transplantation Due to Overexpression of α1 Collagen V.
E. Daoud,¹ Y. Butt,¹ F. Torres,² T. Jose.¹
¹Pathology, University of Texas Southwestern Medical Center, Dallas, TX; ²Lung Transplant Program, University of Texas Southwestern Medical Center, Dallas, TX
The mechanism of fibrosing vasculopathy in lung allograft is poorly understood. A 58 year old man received a bilateral lung transplant for interstitial lung disease.…
2017 American Transplant Congress
Conservative Management of Pneumatosis Intestinalis After Pediatric Liver Transplantation.
R. Hendrickson, J. Ryan, L. Dandridge, W. Andrews, J. Daniel, R. Fischer, D. Rivard.
Transplant Surgery, Developmental and Behavior Sciences, Hepatology and Radiology, Children's Mercy Hospital, Kansas City, MO
BACKGROUND: Pnuematosis intestinalis (PI), characterized by gas in the bowel wall, is a rare pathologic finding in pediatric liver transplantation (PLT) recipients. PI has been…
2017 American Transplant Congress
Impact of Pretransplant Panel-Reactive Antibody Level on Ocular Surface Stem Cell Survival and Visual Outcome.
A. Govil,¹ A. Cheung,² E. Sarnicola,² B. Genereux,² E. Holland.²
¹University of Cincinnati, Cincinnati, OH; ²Cincinnati Eye Institute, Cincinnati, OH
Purpose: Panel-Reactive Antibody (PRA) is a screening test for a range of known human leukocyte antigens which signifies the proportion of the population that the…
2017 American Transplant Congress
The Role of Anti-Neu5Gc IgM in Xenograft Antibody Mediated Rejection.
W. Hassanein,¹ G. Braileanu,¹ L. Burdorf,¹ W. Sun,¹ B. French,¹ C. Laird,¹ S. Sendil,¹ C. Ahn,³ D. Ayares,² R. Pierson III,¹ A. Azimzadeh.¹
¹University of Maryland School of Medcine, Baltimore, MD; ²Revivicor, Blacksburg, VA; ³Seoul National University Hospital, Seoul, Korea
Background:Acute antibody mediated rejection due to preformed antibodies present in human serum remains a hurdle to successful xenotransplantation. Here, we measured anti-Neu5Gc-IgM antibody titers in…
2017 American Transplant Congress
Correlation of Complement Activating Donor Specific Antibodies as Measured by C3d and Cross-Match Status.
A. Babu,^1,2,3 N. Krishnan,² D. Briggs,³ D. Mitchell,¹ S. Daga.^1,2,4
¹Warwick Medical School, University of Warwick, Coventry, United Kingdom; ²Nephrology and Transplantation, University Hospitals Coventrya and Warwickshire, Coventry, United Kingdom; ³Histocompatibility and Immunogenetics, NHS Blood and Transfusion, Birmingham, United Kingdom; ⁴Nephrology and Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Introduction. Complement dependent cytotoxicity, first described in 1969 is the only functional assay studying complement activation. C3d assay is developed recently to study complement activation…
2017 American Transplant Congress
Warm Ischemic Time as an Additive Predictor of Graft Survival in KDPI/KDRI Era of Kidneys from Donors After Cardiac Death: A Single-Center Experience Over Three Decades.
M. Kusaka,¹ Y. Kubota,¹ H. Takahashi,² H. Sasaki,¹ M. Takenaka,¹ N. Fukami,¹ T. Kenmochi,³ R. Shiroki,¹ K. Hoshinaga.¹
¹Urology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; ²Division of Medical Statistics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; ³Organ Transplant Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan
It is important to predict the outcome of grafts prior to kidney transplantation and establish an appropriate allocation system, particularly to consider expanded criteria donors…